In the last trading session, 2.35 million Ocugen Inc (NASDAQ:OCGN) shares changed hands as the company’s beta touched 4.13. With the company’s per share price at $0.77 changed hands at $0.01 or 1.50% during last session, the market valuation stood at $224.81M. OCGN’s last price was a discount, traded about -163.64% off its 52-week high of $2.03. The share price had its 52-week low at $0.51, which suggests the last value was 33.77% up since then.
Analysts gave the Ocugen Inc (OCGN) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 5 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended OCGN as a Hold, 5 felt it is a Buy and 0 rated the stock as Underweight. Ocugen Inc’s EPS for the current quarter is expected to be -0.06.
Ocugen Inc (NASDAQ:OCGN) trade information
Instantly OCGN was in green as seen at the end of in last trading. With action 9.97%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -4.37%, with the 5-day performance at 9.97% in the green. However, in the 30-day time frame, Ocugen Inc (NASDAQ:OCGN) is 13.31% up.
The consensus price target for the stock as assigned by Wall Street analysts is 5, meaning bulls need an upside of 84.6% from its current market value. According to analyst projections, OCGN’s forecast low is 3.5 with 6 as the target high. To hit the forecast high, the stock’s price needs a -679.22% plunge from its current level, while the stock would need to soar -354.55% for it to hit the projected low.
Ocugen Inc (OCGN) estimates and forecasts
Year-over-year growth is forecast to reach -37.97% down from the last financial year.
Consensus estimates given by 4 financial analysts project the company’s revenue in the current quarter to hit an average of 350k. 4 analysts are of the opinion that Ocugen Inc’s revenue for the current quarter will be 300k. The company’s revenue for the corresponding quarters a year ago was 1.14M and 1.14M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at -69.33%. The estimates for the next quarter sales put growth at -73.59%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 32.82%. The 2025 estimates are for Ocugen Inc earnings to decrease by -15.00%.
Ocugen Inc (NASDAQ:OCGN)’s Major holders
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 6.0311% or 15.52 million shares worth $24.06 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF. With 9.07 shares estimated at $6.99 million under it, the former controlled 3.11% of total outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held about 2.58% of the shares, roughly 7.54 shares worth around $5.81 million.
